/
The  Leishmaniases Leishmaniases The  Leishmaniases Leishmaniases

The Leishmaniases Leishmaniases - PowerPoint Presentation

GymRat
GymRat . @GymRat
Follow
342 views
Uploaded On 2022-07-27

The Leishmaniases Leishmaniases - PPT Presentation

Clinical Phenotypes Cutaneous Leishamaniasis Mucocutaneous Leishmaniasis Visceral Leishmaniasis Post Kalaazar dermal leishmaniasis Phenotypes o f the Leishmaniases VISCERAL LEISHMANIASIS ID: 929627

cutaneous leishmaniasis leishmaniases visceral leishmaniasis cutaneous visceral leishmaniases amastigotes infected brazil state million promastigotes vaccines sudan fever kala azar

Share:

Link:

Embed:

Download Presentation from below link

Download Presentation The PPT/PDF document "The Leishmaniases Leishmaniases" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript

Slide1

The Leishmaniases

Slide2

Leishmaniases Clinical Phenotypes

Cutaneous

Leishamaniasis

Mucocutaneous

Leishmaniasis

Visceral

Leishmaniasis

Post Kala-azar dermal

leishmaniasis

Slide3

Phenotypes

o

f the

Leishmaniases

VISCERAL LEISHMANIASIS

(Bangladesh, Brazil, India, Nepal and Sudan)

CUTANEOUS LEISHMANIASIS

(

Afghanistan, Brazil, Iran, Peru, Saudi Arabia and Syria)

DIFFUSE CUTANEOUS LEISHMANIASIS

MUCO CUTANEOUS LEISHMANIASIS

(

Bolivia, Brazil and Peru.

Post kala azar dermal

leishmaniasis

(Prevalent in Sudan and India, ?Europe/HIV)

Slide4

The leishmaniasis is endemic in 88 countries on five continents—Africa, Asia, Europe, North America and South America.

350 million people at risk.

12 million people are affected by leishmaniasis

1.5-2 million new cases of leishmaniasis estimated to occur annually.

500 000 new cases of VL which occur annually

GEOGRAPHICAL DISTRIBUTION

Slide5

SUDAN

Gedarif

State

Blue Nile State

White Nile State

West

Darfour

Southern

Korddofan

Slide6

CUTANEOUS LEISHMANIASIS

skin ulcers on the exposed parts of the body, such as the face, arms and legs

Slide7

MUCOCUTANEOUS LEISHMANIASIS

OR

ESPUNDIA

Mucous

membranes of the nose

Mouth Throat cavities

Slide8

Cutaneous Leishmaniasis

Cutaneous

Leishmaniasis

Muco

-cutaneous

Slide9

Slide10

Slide11

PROMASTIGOTES

AMASTIGOTES

Slide12

Visceral Leishmaniasis

Visceral

Leishmaniasis

Slide13

kala

azar, black fever,

sandfly

disease, Dum-Dum

fever

OTHER NAMES

(

SYNONYMS)

Slide14

Slide15

Visceral leishmaniasis

Irregular

bouts of fever

Substantial

weight loss

Swelling of the spleen, Lymph nodes and liver Anaemia or Pancytopenia

Slide16

Anthroponotic

LIFE

CYCLE

Slide17

1.

Leishmaniasis

is transmitted by the bite of female

phlebotomine

sandflies.

2. Promastigotes that reach the puncture wound are phagocytized by macrophages.

3.They transform into amastigotes.4. Amastigotes multiply in infected cells and affect different tissues.

5. Sandflies become infected during blood meals on an infected host when they ingest macrophages infected with amastigotes.

6. In the

sandfly's

midgut, the parasites differentiate into promastigotes.

7. They multiply and migrate to the proboscis.

Slide18

Diagnosis Of The

Leishmaniases

L.D BODIES (SPLEEN, BONE MARROW, LYMPH NODE

) Aspirates

DAT, rK39, rK28

ELISA

Polymerize chain reaction (PCR)

Leishmanin

Skin Test [LST]

Slide19

TREATMENT

SODIUM

ANTIMONY STIBO

GLUCONATE/

Paromomycin

Liposomal AMPHOTERICIN-B

Miltefosine

(

Impavido

®)

(

approval by the Indian and German Regulatory Authorities (2003)

Slide20

Leishmaniasis

Control

Case Detection and Treatment

Vector Control

Bed Nets

Vaccines!!

Slide21

Vaccines for Leishamaniasis

Phase I/II/III Trials with a first-

generation vaccine (killed

Leishmania

organism BCG (adjuvant) have yielded promising results

Alum/ALM +BCG very promising!

Second/Third Generation Vaccines!!!

Related Contents


Next Show more